Most Read Articles
one year ago
Adjunct boceprevir is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study.
2 years ago
Current management of liver abscess is by intravenous antibiotics and percutaneous treatment. The efficacy of this management was assessed in this study.
Jackey Suen, 2 years ago
Over one-third of patients with prior hepatitis B virus (HBV) exposure had HBV reactivation 2 years after haematopoietic stem cell transplantation (HSCT), according to a study by The University of Hong Kong (HKU). 
2 years ago
A randomised controlled trial demonstrated the safety of low-dose peginterferon α-2b with escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1.

Treatment of alcoholic hepatitis – Role of S-adenosyl-L-methionine (SAMe)

6 months ago
At a recent Abbott-sponsored satellite symposium held during the GUT Congress 2016 in Kuala Lumpur, an expert from India presented on the management of alcoholic liver disease, and illustrated the role of SAMe as a complementary therapy.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Adjunct boceprevir is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study.
2 years ago
Current management of liver abscess is by intravenous antibiotics and percutaneous treatment. The efficacy of this management was assessed in this study.
Jackey Suen, 2 years ago
Over one-third of patients with prior hepatitis B virus (HBV) exposure had HBV reactivation 2 years after haematopoietic stem cell transplantation (HSCT), according to a study by The University of Hong Kong (HKU). 
2 years ago
A randomised controlled trial demonstrated the safety of low-dose peginterferon α-2b with escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1.